PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-82.06%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-66.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-123.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-123.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-139.08%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-140.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-142.11%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.85%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.12%
Reduced diluted shares while ECL.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
129.64%
Positive OCF growth while ECL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
120.13%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
142.30%
Positive 10Y revenue/share CAGR while ECL.AX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-24.58%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
13.36%
Positive 3Y CAGR while ECL.AX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
657.42%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
333.39%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
565.52%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
-650.00%
Negative 10Y net income/share CAGR while ECL.AX is at 12.77%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-287.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-475.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
4382.33%
10Y equity/share CAGR above 1.5x ECL.AX's 139.38%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
132.10%
5Y equity/share CAGR is in line with ECL.AX's 136.81%. Walter Schloss would see parallel mid-term profitability and retention policies.
73.11%
3Y equity/share CAGR at 50-75% of ECL.AX's 106.52%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while ECL.AX invests at 424.82%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-41.70%
Firm’s AR is declining while ECL.AX shows 37.68%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.93%
Inventory growth of 4.93% while ECL.AX is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-9.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.60%
We have a declining book value while ECL.AX shows 0.28%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-63.18%
We’re deleveraging while ECL.AX stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.16%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.